VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ATGEAdtalem Global Education Inc.
$106.64$3.7B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksATGECash Flow

Adtalem Global Education Inc. (ATGE) Cash Flow Statement

30Y historyFree accessUpdated daily

Free cash flow remains highly sensitive to academic cycles, evidenced by a volatile swing from a $197.7 million inflow in 2025Q3 to a $29.7 million outflow in 2025Q2.

ATGE Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMJun'25Jun'24Jun'23Jun'22Jun'21Jun'20Jun'19Jun'18Jun'17Jun'16Jun'15Jun'14Jun'13Jun'12Jun'11Jun'10Jun'09Jun'08Jun'07Jun'06Jun'05Jun'04Jun'03Jun'02Jun'01Jun'00Jun'99Jun'98Jun'97Jun'96
Cash from Operations427.89M337.9M295.77M191.91M10.6M192.2M107.69M204.86M239.19M227.96M231.57M203.11M262.92M263.95M277.42M407.99M391.55M249.53M198.65M125.18M90.82M87.56M134.43M98.25M115.32M85.22M71.33M54.6M47.6M42.4M28.4M
Operating CF Margin %-18.9%18.67%13.23%0.77%21.37%12.43%16.53%19.43%12.6%12.56%10.63%13.67%13.44%13.28%18.69%20.44%17.07%18.19%13.41%10.77%11.21%17.13%14.46%17.81%15%14.12%13.02%13.53%13.8%10.97%
Operating CF Growth %385.01%14.24%54.12%1710.34%-94.48%78.47%-47.43%-14.35%4.92%-1.56%14.01%-22.75%-0.39%-4.86%-32%4.2%56.92%25.61%58.69%37.83%3.73%-34.87%36.82%-14.8%35.33%19.46%30.65%14.71%12.26%49.3%0.71%
Net Income253.25M237.06M137.71M101.75M-35.95M70.03M71.39M136.02M114.44M123.28M-2.76M135.12M151.67M125.74M142.38M330.83M279.98M165.61M125.53M76.19M43.05M28.54M58.06M61.15M67.06M57.78M47.78M38.8M30.7M24.2M19.2M
Depreciation & Amortization86.04M84.47M107.96M151.09M186.6M84.54M100.97M51.74M52.82M84.06M85.55M90.56M89.82M93.25M88.69M64.57M62.22M50.45M39.87M44.01M48.11M57.57M55.58M40.33M33.54M32.04M25.25M17.8M14M11.3M7.6M
Stock-Based Compensation42.2M41.59M25.95M14.3M22.61M12.82M13.88M13.22M14.5M16.6M22.37M17.44M17.68M15.49M18.53M14.25M10.15M7.55M5.72M5.43M4.34M0000000000
Deferred Taxes52.81M18.41M11.07M-5.09M-544K62K-4.55M20.76M-10.6M5.6M-41.65M3.56M-17.11M-12.46M-10.16M23.97M-9.55M344K3.11M4.59M-475K-5.78M5.47M8.94M2.63M-4.32M-3.16M-4.5M-1M2M-500K
Other Non-Cash Items73.73M70.94M65.99M33.65M-78.91M32.23M36.17M29.56M86.11M101.47M236.8M98.28M94.47M138.27M182.82M91.21M87.64M76.01M55.76M30.79M47.01M1K-2K34.76M34.44M29.8M24.22M200K200K16.7M-1.2M
Working Capital Changes-79.38M-114.58M-52.91M-103.79M-83.2M-7.48M-110.18M-46.45M-18.09M-103.05M-68.75M-141.85M-73.61M-96.34M-144.84M-116.84M-38.9M-50.44M-31.36M-35.83M-51.21M-37.1M-20.62M-46.93M-22.34M-30.07M-22.76M-18M-12.6M-11.8M-12.8M
Change in Receivables-81.05M-80.82M-76.36M-56.31M-41.39M13.26M-12.84M-27.71M-43.29M-100.12M-91.65M-96.53M-82.26M-124.45M-90.24M-84.94M-102.59M-89.25M-59.95M-47.74M-55.12M0000000000
Change in Inventory00000-22.63M-71.64M-17.85M11.86M-5.97M20.09M-44.44M12.57M39.84M-38.99M1.67M-110.88M48.46M-122.3M-2K45K3.13M1.03M592K-8K1.49M304K-1.3M-700K-1.3M300K
Change in Payables33.25M140K18.33M24.74M-15.72M8.53M-6.34M9.2M9.96M755K-9.61M10.83M-2.88M-6.7M-1.58M-26.81M18.78M-3.08M36M-5.38M9.17M0000000000
Cash from Investing-57.35M-41.92M-47.85M23.74M-551.8M-56.69M382.52M-213.84M-71.45M-379.65M-215.41M-155.88M-84.32M-152.63M-380.01M-125.99M-85.79M-389.39M-100M-1.92M-26M-47.77M-44.3M-339.67M-85.87M-83.12M-79.38M-44.8M-31.8M-28.8M-53.2M
Capital Expenditures-59.88M-50.33M-48.89M-26.01M-31.05M-48.66M-44.14M-64.75M-66.53M-48.99M-69.4M-88.71M-79.36M-111.78M-129.06M-135.73M-131.01M-74.04M-62.81M-38.56M-25.27M-42.91M-42.81M-43.76M-85.87M-74.55M-40.8M-44.8M-31.8M-28.8M-36.3M
CapEx % of Revenue3.17%2.81%3.09%1.79%2.25%5.41%5.09%5.22%5.4%2.71%3.76%4.64%4.13%5.69%6.18%6.22%6.84%5.07%5.75%4.13%3%5.49%5.45%6.44%13.26%13.12%8.07%10.68%9.04%9.37%14.02%
Acquisitions7.33M7.33M00-1.49B48.66M44.14M-118.41M-9.04M-330.57M-176.98M-73.12M-13.57M-39.03M-255.37M-3.03M0-315.32M-27.6M0-2.53M-4.86M-1.49M-295.91M0-8.57M-38.59M0000
Investments-------------------------------
Other Investing-5M0043.63M967.48M-48.66M271.99M-26.2M-62.25M-48.99M31.07M6.1M8.73M-111.78M-129.06M-627K-700K39K52.57M36.64M1.8M000000000-16.9M
Cash from Financing-507.32M-316.02M-301.8M-288.51M-424.48M676.47M-256.11M-137.53M37.2M88.8M-65.62M-48.61M-16.51M-85M-168.02M-140.19M-161.84M86.17M-11.28M-124.23M-95.53M-23.91M-37.37M290.4M1.07M982K2.07M-9.7M-22.9M-4.7M28.6M
Debt Issued (Net)-50M-100M-50M-150.86M-229.71M797M-107.8M107M175M120.18M-11.5M-5.98M-9.1M-3.82M00-124.81M112.07M-1.9M-125M-100M-25M-40M290M000-10M-23M-28.5M28.5M
Equity Issued (Net)-4M-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K0-1000K-1000K-1000K-1000K-1000K-1000K1000K1000K1000K1000K404K1000K982K659K341K100K1000K100K
Dividends Paid000000000-11.41M-22.98M-23.23M-21.9M-31.53M-18.37M-15.53M-12.84M-10.02M-7.84M-3.54M00000000000
Share Repurchases-311.42M-213.13M-261.97M-123.13M-120M-100M-136.89M-252.85M-137.03M-48.51M-32.63M-25.92M0-53.89M-158.09M-132.94M-41.68M-33.68M-24.46M-10.53M00000000000
Other Financing-146.69M-14.2M10.17M-14.52M-74.76M-16.33M-11.42M15.12M3.44M28.54M1.49M6.51M11.85M6.68M8.44M8.28M17.49M17.79M4.2M972K532K582K471K0000-41K000
Net Change in Cash-136.78M-20.04M-53.87M-72.86M-965.68M812.51M200.64M-143.94M179.9M-64.25M-44.86M-5.17M161.04M22.5M-273.07M139.44M142.5M-52M88.04M-1.43M-31.24M15.6M52.76M49.01M30.47M3.36M-6M-100K-7M8.9M3.8M
Free Cash Flow368.01M287.57M246.88M165.9M-20.45M143.53M63.55M140.11M172.66M178.97M162.17M114.4M183.57M152.17M148.37M272.26M260.54M175.48M135.84M86.62M65.56M44.65M91.62M54.49M29.45M10.67M30.54M9.8M15.8M13.6M-7.9M
FCF Margin %19.48%16.08%15.58%11.43%-1.48%15.96%7.34%11.3%14.02%9.89%8.8%5.99%9.54%7.75%7.1%12.48%13.6%12.01%12.44%9.28%7.77%5.71%11.67%8.02%4.55%1.88%6.04%2.34%4.49%4.43%-3.05%
FCF Growth %57.39%16.48%48.81%911.13%-114.25%125.84%-54.64%-18.85%-3.53%10.36%41.76%-37.68%20.63%2.56%-45.51%4.5%48.47%29.18%56.83%32.13%46.83%-51.27%68.14%85.02%176.11%-65.07%211.6%-37.97%16.18%272.15%-158.09%
FCF per Share10.167.506.133.64-0.422.781.172.362.772.802.521.752.832.362.193.863.612.421.881.210.930.641.290.780.420.150.430.140.230.20-0.12
FCF Conversion (FCF/Net Income)1.45x1.43x2.16x2.06x0.03x2.74x-1.26x1.59x7.08x1.86x-73.14x1.45x1.96x2.47x1.96x1.23x1.40x1.51x1.58x1.64x2.11x3.07x2.57x1.61x1.72x1.47x1.49x1.41x1.55x1.75x1.48x
Interest Paid046.6M57.84M53.13M107.09M14.43M20.16M20.41M11.51M7.33M3.51M1.8M1.74M1.12M1.05M454K867K2.17M0000000000000
Taxes Paid032.78M31.48M12.31M94.36M26.43M12.44M3.23M8.37M14.9M-1.42M23.94M27.86M28.84M80.91M152.55M130.5M60.61M0000000000000

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrong
Balance SheetFortress
Cash FlowMixed
Top Statement Risk

Working capital volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Earnings Quality Subject to Volatility

As reported in recent financial statements, Adtalem's operating cash flow to net income ratio has fluctuated significantly, ranging from a low of -0.25 in 2025Q2 to a high of 8.39 in 2024Q1, indicating that cash generation is frequently decoupled from reported accounting profits.

The wide variance in the OCF/NI ratio suggests that GAAP net income is a poor proxy for short-term liquidity, likely due to the timing of tuition receipts and regulatory refund obligations. Investors should monitor whether this disconnect is a permanent feature of the academic cycle or a sign of underlying collection inefficiencies.

Free Cash Flow Margin Instability

Based on the company's reported figures, free cash flow margins have exhibited extreme volatility, swinging from a negative 6.6% in 2025Q2 to a peak of 42.4% in 2025Q3, reflecting the significant impact of seasonal working capital shifts on the firm's ability to generate surplus cash.

The erratic nature of FCF generation complicates the assessment of the company's true cash-generating capacity. While the business model is inherently profitable, the reliance on specific enrollment windows creates lumpy cash inflows that may mask the underlying operational efficiency of the core nursing and medical segments.

Working Capital Cycles Drive Liquidity

According to recent SEC filings, working capital changes have been a primary driver of cash flow variance, with a massive $149.7 million outflow in 2025Q2 followed by a $92.5 million inflow in 2025Q3, highlighting the sensitivity of cash balances to academic enrollment and billing cycles.

These dramatic swings in working capital suggest that the company's cash position is highly dependent on the timing of student payments and federal funding disbursements. The recurring nature of these outflows warrants further investigation into whether the company is effectively managing its receivables or if it is increasingly exposed to timing mismatches.

Aggressive Capital Return Amidst Fluctuations

As indicated by financial data, Adtalem has prioritized share repurchases, including a $164.8 million buyback in 2026Q2, even during periods where operating cash flow was significantly lower than net income, suggesting a management preference for returning capital despite the inherent volatility in cash generation.

The decision to aggressively repurchase shares while operating cash flow remains inconsistent may indicate high confidence in long-term earnings power. However, this strategy leaves less room for error should regulatory shifts or clinical capacity constraints negatively impact the company's ability to convert tuition into cash.

ATGE — Frequently Asked Questions

Quick answers to the most common questions about buying ATGE stock.

How much cash does Adtalem Global Education Inc. (ATGE) generate from operations?

Adtalem Global Education Inc. (ATGE) generated $337.9M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Adtalem Global Education Inc.'s free cash flow?

Adtalem Global Education Inc. (ATGE) generated $287.6M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Adtalem Global Education Inc.'s capital expenditure (CapEx)?

Adtalem Global Education Inc. (ATGE) spent $50.3M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Adtalem Global Education Inc. distribute cash to shareholders?

In 2025, Adtalem Global Education Inc. (ATGE) spent $213.1M on share repurchases. This shows the company's commitment to returning capital to its equity investors.